The Lancet

People who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca preventive, according to a nationwide study.

Two doses of the Pfizer COVID-19 vaccine are 90 per cent effective against hospitalisation from the disease for all variants, including Delta, for at least six months, according to a study published in The Lancet journal on Tuesday.

Vaccines are effective enough at preventing severe cases of Covid-19 that there is no current need for the general population to be given third doses, according to a report in The Lancet published Monday.

A combination of 2 monoclonal antibody treatments keeps high-risk Covid patients out of the hospital when infected with mild to moderate disease, according to an observational study published in The Lancet's EClinicalMedicine journal.

Around half the people hospitalised with COVID-19 experience at least one persistent symptom up to 12 months after the infection, according to a study published in The Lancet journal on Friday.

There is no immediate evidence to suggest a third COVID-19 wave will affect children more than adults, the National Institute of Disaster Management has said in a report that cites the Indian Academy of Paediatrics and the Lancet COVID-19 Commission.

People who are infected with the virus that causes COVID-19 while pregnant face a higher risk of having a very preterm birth, as well as any preterm birth, according to a large US study published in The Lancet Regional Health - Americas journal.

Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to study published in The Lancet journal.

Alcohol consumption was associated with 62,100 or five per cent of newly diagnosed cancer cases last year in India, according to a study published in The Lancet Oncology journal which shows alcohol use is on the rise in the country.

Nearly 740,000 access deaths in India annually can be attributed to abnormal hot and cold temperatures related to climate change, according to a study published in The Lancet Planetary Health journal.

Two doses of the China-made COVID-19 vaccine, CoronaVac, are safe and produce a strong antibody response among children and adolescents aged 3-17 years, according to a study published in The Lancet Infectious Diseases journal.

A commentary on the website of the medical journal The Lancet authored by 21 people including Biocon's Kiran Mazumdar Shaw and top surgeon Dr Devi Shetty has recommended eight actions to prepare for a possible resurgence of COVID-19 cases in India.

A single day rise of 67,208 new coronavirus infections were recorded taking India's total tally of COVID-19 cases to 2,97,00,313, while the active cases declined to 8,26,740, the lowest after 71 days, according to the Union Health Ministry data.

The Pfizer vaccine is far less effective against the Delta variant of Covid, which is dominant in India, compared to the original strain of the coronavirus, says The Lancet journal in a new study.

People who got Pfizer-BioNTech vaccine are likely to have more than 5 times lower levels of neutralising antibodies against Delta variant first identified in India compared to original strain, according to research published in The Lancet journal.

People who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca preventive, according to a nationwide study.

Two doses of the Pfizer COVID-19 vaccine are 90 per cent effective against hospitalisation from the disease for all variants, including Delta, for at least six months, according to a study published in The Lancet journal on Tuesday.

Vaccines are effective enough at preventing severe cases of Covid-19 that there is no current need for the general population to be given third doses, according to a report in The Lancet published Monday.

A combination of 2 monoclonal antibody treatments keeps high-risk Covid patients out of the hospital when infected with mild to moderate disease, according to an observational study published in The Lancet's EClinicalMedicine journal.

Around half the people hospitalised with COVID-19 experience at least one persistent symptom up to 12 months after the infection, according to a study published in The Lancet journal on Friday.

There is no immediate evidence to suggest a third COVID-19 wave will affect children more than adults, the National Institute of Disaster Management has said in a report that cites the Indian Academy of Paediatrics and the Lancet COVID-19 Commission.

People who are infected with the virus that causes COVID-19 while pregnant face a higher risk of having a very preterm birth, as well as any preterm birth, according to a large US study published in The Lancet Regional Health - Americas journal.

Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to study published in The Lancet journal.

Alcohol consumption was associated with 62,100 or five per cent of newly diagnosed cancer cases last year in India, according to a study published in The Lancet Oncology journal which shows alcohol use is on the rise in the country.

Nearly 740,000 access deaths in India annually can be attributed to abnormal hot and cold temperatures related to climate change, according to a study published in The Lancet Planetary Health journal.

Two doses of the China-made COVID-19 vaccine, CoronaVac, are safe and produce a strong antibody response among children and adolescents aged 3-17 years, according to a study published in The Lancet Infectious Diseases journal.

A commentary on the website of the medical journal The Lancet authored by 21 people including Biocon's Kiran Mazumdar Shaw and top surgeon Dr Devi Shetty has recommended eight actions to prepare for a possible resurgence of COVID-19 cases in India.

A single day rise of 67,208 new coronavirus infections were recorded taking India's total tally of COVID-19 cases to 2,97,00,313, while the active cases declined to 8,26,740, the lowest after 71 days, according to the Union Health Ministry data.

The Pfizer vaccine is far less effective against the Delta variant of Covid, which is dominant in India, compared to the original strain of the coronavirus, says The Lancet journal in a new study.

People who got Pfizer-BioNTech vaccine are likely to have more than 5 times lower levels of neutralising antibodies against Delta variant first identified in India compared to original strain, according to research published in The Lancet journal.